NCT02180997

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Pharmacokinetic Drug Interaction Between Solifenacin 10mg and Tamsulosin 0.4mg in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the pharmacokinetic drug interaction between Solifenacin and Tamsulosin in healthy male volunteers.

Detailed description

Pharmacokinetic Drug Interaction Between Solifenacin 10mg and Tamsulosin 0.4mg in Healthy Male Volunteers

Conditions

• LUTS
• Benign Prostatic Hyperplasia
• Overactive Bladder

Interventions

Type	Name	Description
DRUG	Tamsulosin	Tamsulosin and solifenacin: Tamsulosin 0.4mg, once daily
DRUG	Solifenacin	Tamsulosin and solifenacin: Solifenacin 10 mg, once daily
DRUG	Tamsulosin and solifenacin	Tamsulosin and solifenacin: Tamsulosin 0.4mg, once daily, Solifenacin 10 mg, once daily

Timeline

• Start date: 2014-07-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2014-07-03
• Last updated: 2016-06-24

Locations

1 site across 1 country: South Korea